About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Until 2017, this group was constituted as a consolidated group in the VHIR under the name of "Digestive Transplants" with a consolidated research trajectory. Our group has two large areas of research: liver transplantation, which is cross-sectional adult-pediatric and; on the other hand, research, specifically in the fields of liver resections, liver cancer (primary or metastatic), biliary cancer, pancreatic cancer and pancreatitis. Both areas have very innovative aspects, with translational objectives, including artificial intelligence, transcriptomics and molecular biology.
The general objective of the liver transplant research area is to improve the preservation of liver grafts, as well as increase the survival of grafts and transplant patients. The research area related to cancer or acute pancreatitis has as a general objective to improve the management and treatment of patients with pancreatitis, as well as to improve the diagnosis and survival of cancer patients.
Podria restaurar la ureagènesi en pacients pediàtrics amb trastorns del cicle de la urea.
IP: Jesús Quintero Bernabeu, Javier Juamperez Goñi, Maria Margaret Mercadal Hally
- PancreatIA-EmergencyCare: Algoritme de predicció de la gravetat de la pancreatitis aguda utilitzant "machine learning" i processament de imatges.
- PancreatIA-Cancer: Algoritme de predicció de recurrència del càncer de pàncreas post- cirurgia utilitzant "machine learning" i processament de imatges així como las mutacions genètiques del tumor.
IP: Elizabeth Pando Rau, Joaquin Balsells Valls
El desenvolupament de algoritmes de “machine learning” de forma objectiva, ràpida i reproduïble, per detectar i quantificar el grau d´esteatosi. També plataforma d´entrenament d´algoritmes amb dades i imatges médiques.
IP: Concepción Gomez Gavara, Itxarone Izaskun Bilbao Aguirre, Elizabeth Pando Rau
La seva correlació amb dades clíniques, analítiques, d'imatge i amb un panell de miRNA (miR-155-5p, miR-122-5p, miR-181a -5p, miR-148-3p ) podria permetre la individualització del tractament immunosupressor.
IP: Joaquin Balsells Valls Collaborators: Gianluca Pellino Funding agency: Asociación Española de Cirujanos Funding: 5000 Reference: AEC/BECA/2022/IBD/FERTILITY Duration: 18/10/2022 - 19/10/2025
IP: Concepción Gomez Gavara Collaborators: Ramon Charco Torra, Ernest Hidalgo Llompart, Enric Miret Alomar, Elizabeth Pando Rau Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2021 SGR 01236 Duration: 01/01/2022 - 30/06/2025
IP: Chaysavanh Manichanh Collaborators: Itxarone Izaskun Bilbao Aguirre, Zaida Soler Luque, Jordi Barquinero Mañez, Oscar Segarra Canton, Gerard Serrano Gomez, Cristina Dopazo Taboada, Rocío Piñera Moreno Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 40000 Reference: 2021 SGR 00459 Duration: 01/01/2022 - 30/06/2025
IP: Alberto Sandiumenge Camps Collaborators: Ernest Hidalgo Llompart, Jesús Quintero Bernabeu Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 124939 Reference: CPP2021-008633 Duration: 01/09/2022 - 06/08/2025
The document provides a comprehensive evaluation of current knowledge on this type of cancer affecting the bile ducts.
Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research
L’aportació permet avançar en estudis de referència internacional i continuar millorant l’atenció dels infants trasplantats de fetge.
